Resources Contact Us Home
Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis

Image Number 18 for United States Patent #7285268.

The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.

  Recently Added Patents
Direct connect single layer touch panel
System and method for conditionally sending a request for data to a home node
Compositions, organisms, systems, and methods for expressing a gene product in plants using SCBV expression control sequences operable in monocots and dicots
Live-attenuated compositions for bacterial infections
Motion compensated overlay
Faucet handle
Normalized contextual performance metric for the assessment of fatigue-related incidents
  Randomly Featured Patents
Adjustable convex rearview mirror
Recording and/or reproducing apparatus using signal processing program information
Method of making a permeable ceramic tile insulation
Method, apparatus and product for RFID authentication
Coupon inserting apparatus and method
Taillight fixture of a vehicle preferably a motor vehicle
Apparatus and method for automatically adjusting tilting of an optical disc drive
Methine compound, material for organic luminescence element, organic luminescence element using the same
Vehicle rearview mirror system